Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/18/2024 | $11.75 | Buy | Berenberg |
| 9/19/2024 | $12.00 | Buy | Alliance Global Partners |
| 10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
| 10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/7/2022 | Mkt Perform | JMP Securities | |
| 1/13/2022 | Overweight → Sector Weight | Keybanc | |
| 9/20/2021 | $17.00 | Overweight | Keybanc |
| 7/9/2021 | $18.00 | Buy | Colliers Securities |
Issues Letter to Stockholders to Outline the Case for Meaningful Change at Brookdale Following Years of Underperformance Ortelius' Nominees Bring Extensive Experience in Senior Housing, Real Estate, Operations, Capital Markets, and Turnaround Situations Believes New and Energized Board Will Drive Urgent Change and Unlock Significant Value for Stockholders Ortelius Advisors, L.P. today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD). The full text of the letter follows: March 5, 2025 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") owns approximately 1.3% of the outstanding common stock of Brookdale Senior Living Inc.1
– Acquires $80.3 Million of Single Tenant Triple-Net Medical Real Estate in 2024 – – Announces Joint Venture with Heitman – – Announces First Quarter 2025 Common and Preferred Dividends – – Announces Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three and twelve months ended December 31, 2024 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the year we maintain
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that it intends to release its fourth quarter and year-end 2024 financial results after the market closes on Thursday, February 27, 2025. The Company intends to hold a conference call to discuss those results the following day, Friday, February 28, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by Chairman, President, and Chief Executive Officer Jeffrey Busch, Chief Financial Officer Robert Kiernan, and Chief
10-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75
Alliance Global Partners initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $12.00
Robert W. Baird downgraded Global Medical REIT from Outperform to Neutral and set a new price target of $9.00
Issues Letter to Stockholders to Outline the Case for Meaningful Change at Brookdale Following Years of Underperformance Ortelius' Nominees Bring Extensive Experience in Senior Housing, Real Estate, Operations, Capital Markets, and Turnaround Situations Believes New and Energized Board Will Drive Urgent Change and Unlock Significant Value for Stockholders Ortelius Advisors, L.P. today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD). The full text of the letter follows: March 5, 2025 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") owns approximately 1.3% of the outstanding common stock of Brookdale Senior Living Inc.1
– Acquires $80.3 Million of Single Tenant Triple-Net Medical Real Estate in 2024 – – Announces Joint Venture with Heitman – – Announces First Quarter 2025 Common and Preferred Dividends – – Announces Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three and twelve months ended December 31, 2024 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the year we maintain
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that it intends to release its fourth quarter and year-end 2024 financial results after the market closes on Thursday, February 27, 2025. The Company intends to hold a conference call to discuss those results the following day, Friday, February 28, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by Chairman, President, and Chief Executive Officer Jeffrey Busch, Chief Financial Officer Robert Kiernan, and Chief
Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,